title: The effect of verapamil on response of coronary vasomotion to handgrip exercise in symptomatic patients with hypertrophic cardiomyopathy.
abstract: OBJECTIVE
  To assess the effect of verapamil on the response of diastolic coronary blood flow velocity (CBFV) and coronary vascular resistance index to handgrip exercise in symptomatic HCM patients.
  
  
  METHODS
  In 13 patients with HCM, the CBFV was detected in the distal portion of left anterior descending coronary artery using high-sensitivity transthoracic Doppler echocardiography. The peak diastolic CBFV and coronary vascular resistance index (calculated as the ratio of mean aortic pressure to CBFV) was measured at baseline and during handgrip exercise. Changes of these parameters induced by the exercise (expressed as the percentage of baseline values) were compared on verapamil treatment and after verapamil withdrawal. The same measurements were obtained in 10 healthy control subject.
  
  
  RESULTS
  In HCM patients, the increase in CBFV during exercise was significantly higher on than off verapamil therapy (16.2 +/- 5% versus 6.8 +/- 3.8%, p < 0.001). In healthy controls, exercise-induced increase in CBFV was comparable to CBFV changes in HCM patients receiving verapamil (17.4 +/- 5.7 versus 16.2 +/- 5%, p > 0.05) and was significantly greater than the CBFV response in HCM patients off verapamil (17.4 +/- 5.7% versus 6.8 +/- 3.8% p < 0.005). During exercise the coronary vascular resistance index decreased on verapamil and increased after drug withdrawal (-5.8 +/- 5.6% versus 1.1 +/- 5.1%, p < 0.001). In healthy controls the coronary vascular resistance index decreased during exercise -8.5 +/- 4.5% to similar extent as in HCM patients on verapamil.
  
  
  CONCLUSIONS
  In HCM symptomatic patients, verapamil improved coronary vasomotor response to physical stress. Verapamil was able to restore adequate vasodilator response to handgrip exercise.
authors.affiliation: 2nd Department of Cardiology, Jagiellonian University School of Medicine, Krakow, Poland. dimitrow@mp.pl
authors.forename: P P
authors.initials: PP
authors.lastname: Dimitrow
authors.forename: M
authors.initials: M
authors.lastname: Krzanowski
authors.forename: R
authors.initials: R
authors.lastname: Nitankowski
authors.forename: A
authors.initials: A
authors.lastname: Szczeklik
authors.forename: J S
authors.initials: JS
authors.lastname: Dubiel
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D002312:Cardiomyopathy, Hypertrophic / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D003326:Coronary Circulation / Q000187:drug effects*; D005080:Exercise Test; D005260:Female; D018737:Hand Strength / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014463:Ultrasonography; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents; D014700:Verapamil